Teri L. Lawver, Chief Officer of Celldex Therapeutics CLDX, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/25.

TL

TL

Teri L. Lawver

SVP & Chief Commercial Officer

Company

Celldex Therapeutics CLDX

First filing

23/03/10

Trades

8 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

06/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
DexcomDXCM	Open-market sale	24/03/12	24/03/14	4,764 sh	$134.41	$640,329.24	−6.7%